Quoin Pharmaceuticals (QNRX)
(Delayed Data from NSDQ)
$0.85 USD
+0.19 (28.79%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $0.84 -0.01 (-1.18%) 5:30 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.39 |
Last EPS Surprise | 48.00% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.02 |
Next Year | -0.50 |
EPS (TTM) | -5.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.44 | -2.02 | -0.50 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.44 | -0.44 | -2.02 | NA |
High Estimate | -0.44 | -0.44 | -2.02 | -0.50 |
Low Estimate | -0.44 | -0.44 | -2.02 | -0.50 |
Year ago EPS | -1.95 | -2.08 | -9.64 | -2.02 |
Year over Year Growth Est. | 77.44% | 78.85% | 79.05% | 75.25% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.44 | -2.02 | -0.50 |
7 Days Ago | -0.44 | -0.44 | -2.02 | -0.50 |
30 Days Ago | -0.44 | -0.44 | -2.02 | -0.50 |
60 Days Ago | -0.57 | -0.57 | -2.79 | -0.50 |
90 Days Ago | -0.57 | -0.57 | -2.79 | -0.50 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.44 | -2.02 | -0.50 |
Zacks Consensus Estimate | -0.44 | -0.44 | -2.02 | -0.50 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.39 | -1.11 | -2.08 | -1.95 | NA |
Estimate | -0.75 | NA | -2.37 | -2.40 | NA |
Difference | 0.36 | NA | 0.29 | 0.45 | 0.37 |
Surprise | 48.00% | NA | 12.24% | 18.75% | 26.33% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more